Clinical trial design in the neurocritical care unit

C. E. Hall, M. Mirski, Y. Y. Palesch, M. N. Diringer, A. I. Qureshi, C. S. Robertson, R. Geocadin, C. A.C. Wijman, P. D. Le Roux, Jose I. Suarez

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.

Original languageEnglish
Pages (from-to)6-19
Number of pages14
JournalNeurocritical Care
Issue number1
StatePublished - Feb 2012


  • Funding
  • Industry
  • NIH
  • Neurocritical care
  • Surrogate markers


Dive into the research topics of 'Clinical trial design in the neurocritical care unit'. Together they form a unique fingerprint.

Cite this